ArticleBlood advances2023

Soluble CD163 predicts outcome in both chemoimmunotherapy and targeted therapy-treated mantle cell lymphoma.

Anna Nikkarinen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.